MX381687B - Compuestos aromaticos sustituidos y composiciones farmaceuticas para la autorreparacion y regeneracion de tejido. - Google Patents

Compuestos aromaticos sustituidos y composiciones farmaceuticas para la autorreparacion y regeneracion de tejido.

Info

Publication number
MX381687B
MX381687B MX2017006281A MX2017006281A MX381687B MX 381687 B MX381687 B MX 381687B MX 2017006281 A MX2017006281 A MX 2017006281A MX 2017006281 A MX2017006281 A MX 2017006281A MX 381687 B MX381687 B MX 381687B
Authority
MX
Mexico
Prior art keywords
sub
tissue
repair
alkenyl
alkyl
Prior art date
Application number
MX2017006281A
Other languages
English (en)
Spanish (es)
Other versions
MX2017006281A (es
Inventor
Lyne Gagnon
Pierre Laurin
Original Assignee
Prometic Pharma Smt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Pharma Smt Ltd filed Critical Prometic Pharma Smt Ltd
Publication of MX2017006281A publication Critical patent/MX2017006281A/es
Publication of MX381687B publication Critical patent/MX381687B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32Phenylacetic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/42Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2017006281A 2014-11-12 2015-11-12 Compuestos aromaticos sustituidos y composiciones farmaceuticas para la autorreparacion y regeneracion de tejido. MX381687B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462078704P 2014-11-12 2014-11-12
PCT/CA2015/000572 WO2016074068A1 (en) 2014-11-12 2015-11-12 Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Publications (2)

Publication Number Publication Date
MX2017006281A MX2017006281A (es) 2017-08-14
MX381687B true MX381687B (es) 2025-03-13

Family

ID=55953490

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006281A MX381687B (es) 2014-11-12 2015-11-12 Compuestos aromaticos sustituidos y composiciones farmaceuticas para la autorreparacion y regeneracion de tejido.

Country Status (19)

Country Link
US (3) US10391073B2 (enExample)
EP (1) EP3217968A4 (enExample)
JP (1) JP6720169B2 (enExample)
KR (1) KR20170072352A (enExample)
CN (1) CN107106526B (enExample)
AR (1) AR102634A1 (enExample)
AU (2) AU2015345943B2 (enExample)
BR (1) BR112017009899A2 (enExample)
CA (1) CA2967499C (enExample)
IL (1) IL252221B (enExample)
MX (1) MX381687B (enExample)
MY (1) MY187515A (enExample)
PH (1) PH12017500856A1 (enExample)
RU (1) RU2728782C2 (enExample)
SG (1) SG11201703741TA (enExample)
TW (1) TWI723967B (enExample)
UY (1) UY36399A (enExample)
WO (1) WO2016074068A1 (enExample)
ZA (1) ZA201703579B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
UY36399A (es) * 2014-11-12 2016-06-30 Prometic Biosciences Inc Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2289417C1 (ru) * 2005-04-15 2006-12-20 Равиль Шамилевич Мирхайдаров Способ биологического омоложения кожи
EP1953222A1 (en) * 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
PL2427416T3 (pl) 2009-05-04 2016-09-30 Podstawione związki aromatyczne i ich zastosowania farmaceutyczne
PL2427417T3 (pl) * 2009-05-04 2014-03-31 Prometic Pharma Smt Ltd Sole kwasu 3-pentylofenylooctowego i ich farmaceutyczne zastosowania
ES2351005B1 (es) * 2009-07-10 2011-11-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de anhidrasa carbónica ii para la elaboración de un medicamento.
CA2816094A1 (en) * 2010-10-27 2012-07-26 Prometic Biosciences Inc. Compounds and pharmaceutical compositions for uses in diabetes
PT2632885T (pt) 2010-10-27 2018-04-04 Prometic Pharma Smt Ltd Compostos carboxilatos de fenilcetona e usos farmacêuticos destes
TWI578983B (zh) 2010-10-27 2017-04-21 波麥堤克藥學Smt有限公司 用於治療癌症的化合物及組成物
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法
WO2013021093A1 (es) * 2011-08-10 2013-02-14 Digna Biotech, S.L. Uso de la cardiotofina-1 para el tratamiento de enfermedades renales
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
ES2875336T3 (es) * 2014-10-10 2021-11-10 Liminal Biosciences Ltd Compuestos aromáticos sustituidos y composiciones farmacéuticas para la prevención y tratamiento de la diabetes
US20180228750A1 (en) * 2014-10-10 2018-08-16 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
UY36399A (es) * 2014-11-12 2016-06-30 Prometic Biosciences Inc Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido

Also Published As

Publication number Publication date
AR102634A1 (es) 2017-03-15
BR112017009899A2 (pt) 2018-01-16
AU2020204112B2 (en) 2021-10-21
WO2016074068A1 (en) 2016-05-19
TWI723967B (zh) 2021-04-11
MY187515A (en) 2021-09-24
US20170312237A1 (en) 2017-11-02
RU2017120401A (ru) 2018-12-13
IL252221A0 (en) 2017-07-31
MX2017006281A (es) 2017-08-14
TW201618764A (zh) 2016-06-01
US20200078324A1 (en) 2020-03-12
SG11201703741TA (en) 2017-06-29
CN107106526A (zh) 2017-08-29
RU2017120401A3 (enExample) 2019-06-06
CN107106526B (zh) 2021-05-28
US10869849B2 (en) 2020-12-22
IL252221B (en) 2022-04-01
EP3217968A1 (en) 2017-09-20
AU2015345943B2 (en) 2020-03-19
UY36399A (es) 2016-06-30
JP2017533928A (ja) 2017-11-16
EP3217968A4 (en) 2018-06-20
PH12017500856A1 (en) 2017-11-06
JP6720169B2 (ja) 2020-07-08
AU2015345943A1 (en) 2017-06-01
CA2967499A1 (en) 2016-05-19
RU2728782C2 (ru) 2020-07-31
US20210085626A1 (en) 2021-03-25
ZA201703579B (en) 2018-08-29
CA2967499C (en) 2023-01-17
AU2020204112A1 (en) 2020-07-09
US10391073B2 (en) 2019-08-27
KR20170072352A (ko) 2017-06-26

Similar Documents

Publication Publication Date Title
EA201100447A1 (ru) Органические соединения
CO2019011873A2 (es) Compuestos de heteroarilo bicíclicos 6–6 fusionados y su uso como inhibidores de lats
PH12015501868A1 (en) Inhibitors of histone demethylases
JOP20190151B1 (ar) مركبات أمينو - ترايازولو بيريدين واستخدامها في علاج سرطان
EA201800367A1 (ru) Способы лечения болезни хантингтона
EA201201648A1 (ru) Стимуляторы sgc
EA201691302A1 (ru) Новые гетероциклические соединения
BR112014013974A8 (pt) derivados de sulfonamida benzílicos como moduladores de rorc
UY30084A1 (es) Compuestos de piperazina con accion herbicida
EA201790693A1 (ru) Коррекция фигуры
EA201390772A1 (ru) Новые соли и полиморфные формы афатиниба
EA200901488A1 (ru) Замещенные имидазолопиридазины, как ингибиторы липидкиназы
EA201390347A1 (ru) Лечение заболеваний
MY192861A (en) 1, 3, 4-thiadiazole compounds and their use in treating cancer
EA201692292A1 (ru) Соединения и композиции для стимулирования хондрогенеза
MX2015017512A (es) Compuestos 2,3-dihidrobenzofuran-5-ilicos como inhibidores de cinasas dyrk.
TW201625535A (en) Inhibitors of histone demethylases
EA201270755A1 (ru) Аналоги пиримидинилпиперидинилоксипиридинона в качестве модуляторов рецептора gpr119
EA201100872A1 (ru) Производные хиназолинамида
EA200970936A1 (ru) СОЕДИНЕНИЯ ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K-АЛЬФА ДЛЯ ЛЕЧЕНИЯ РАКА
EA201890626A1 (ru) ЗАМЕЩЕННЫЕ 1,2-ДИГИДРО-3H-ПИРРОЛО[1,2-c]ИМИДАЗОЛ-3-ОНОВЫЕ АНТИБАКТЕРИАЛЬНЫЕ СОЕДИНЕНИЯ
MX390051B (es) Antagonistas de ep4.
EA201101097A1 (ru) Новые микробиоциды
EA201391304A1 (ru) 2,4-замещенные пиримидиндиамины для применения при дискоидной волчанке
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы